Page last updated: 2024-08-22

titanium and floxuridine

titanium has been researched along with floxuridine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blackshear, PJ; Buchwald, H; Prosl, F; Rohde, TD	1
Arai, W; Haruta, H; Hirashima, Y; Hosoya, Y; Hyodo, M; Kurashina, K; Nagai, H; Saito, S; Sakuma, K; Yasuda, Y; Yokoyama, T; Zuiki, T	1

Other Studies

2 other study(ies) available for titanium and floxuridine

Article	Year
The implantable infusion pump: a new concept in drug delivery. Medical progress through technology, 1979, Nov-30, Volume: 6, Issue:4 Topics: Adult; Animals; Diabetes Mellitus; Diabetic Angiopathies; Dogs; Drug Implants; Electric Power Supplies; Female; Floxuridine; Heparin; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Insulin; Liver Neoplasms; Male; Technology, Pharmaceutical; Thromboembolism; Titanium; Viscosity	1979
Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1. International journal of clinical oncology, 2007, Volume: 12, Issue:2 Topics: Abdominal Neoplasms; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Japan; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pilot Projects; Silicates; Stomach Neoplasms; Survival Analysis; Time Factors; Titanium; Treatment Outcome; Tumor Burden	2007

Article

Year

The implantable infusion pump: a new concept in drug delivery.

Medical progress through technology, 1979, Nov-30, Volume: 6, Issue:4

Topics: Adult; Animals; Diabetes Mellitus; Diabetic Angiopathies; Dogs; Drug Implants; Electric Power Supplies; Female; Floxuridine; Heparin; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Insulin; Liver Neoplasms; Male; Technology, Pharmaceutical; Thromboembolism; Titanium; Viscosity

1979

Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1.

International journal of clinical oncology, 2007, Volume: 12, Issue:2

Topics: Abdominal Neoplasms; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Japan; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pilot Projects; Silicates; Stomach Neoplasms; Survival Analysis; Time Factors; Titanium; Treatment Outcome; Tumor Burden

2007